LitAlert ~~ GeneLit.com

    • Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations.
    • Shani H, Bernstein-Molho R, Laitman Y, Netzer I, Friedman E.
    • Breast Cancer Res Treat. 2021 Jan 15. doi: 10.1007/s10549-020-06084-5. Epub ahead of print.
    • Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection.
    • Brown JM, Wasson MCD, Marcato P.
    • Cancers (Basel). 2021 Jan 15;13(2):E296. doi: 10.3390/cancers13020296.
    • Coffee consumption and breast cancer risk: a narrative review in the general population and in different subtypes of breast cancer.
    • Nehlig A, Reix N, Arbogast P, Mathelin C.
    • Eur J Nutr. 2021 Jan 13. doi: 10.1007/s00394-020-02465-0. Epub ahead of print.
    • Review
    • Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
    • Santos M, Lanillos J, Roldan-Romero JM, Caleiras E, Montero-Conde C, Cascón A, Climent MA, Anguera G, Hernando S, Laínez N, Robledo M, Robles L, de Velasco G, García-Donas J, Rodriguez-Antona C.
    • Genet Med. 2021 Jan 13. doi: 10.1038/s41436-020-01062-0. Epub ahead of print.
    • Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice.
    • Zhang D, Singh B, Moerland J, Mitchell O, Lockwood L, Carapellucci S, Sridhar S, Liby KT.
    • Sci Rep. 2021 Jan 13;11(1):1234. doi: 10.1038/s41598-020-79663-7.
    • Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer.
    • Jönsson JM, Bååth M, Björnheden I, Sahin ID, Måsbäck A, Hedenfalk I.
    • Cancers (Basel). 2021 Jan 12;13(2):E254. doi: 10.3390/cancers13020254.
    • The Relationship Between GSTT1, GSTM1, GSTO1, GSTP1 and MTHFR Gene Polymorphisms and DNA Damage of BRCA1 and BRCA2 Genes in Arsenic-Exposed Workers.
    • Qian S, Tan J, Zhou Q, Yin J, Li H, He Y.
    • J Occup Environ Med. 2021 Jan 12. doi: 10.1097/JOM.0000000000002142. Epub ahead of print.
    • Integrating PARP inhibitors into the management of breast cancer: where are we?
    • Azim HA, Kassem L, Azim H Jr.
    • Chin Clin Oncol. 2020 Dec 31:cco-19-230. doi: 10.21037/cco-19-230. Epub ahead of print.
    • Facilitated cascade testing (FaCT): a randomized controlled trial.
    • Nitecki R, Moss HA, Watson CH, Urbauer DL, Melamed A, Lu KH, Lipkin SM, Offit K, Rauh-Hain JA, Frey MK.
    • Int J Gynecol Cancer. 2020 Dec 18:ijgc-2020-002118. doi: 10.1136/ijgc-2020-002118. Epub ahead of print.
    • Biomarkers in Her2- Positive Disease.
    • Klocker EV, Suppan C.
    • Breast Care (Basel). 2020 Dec;15(6):586-593. doi: 10.1159/000512283. Epub 2020 Oct 28.
    • Review